D89.3 ICD-10-CM Code: Immune reconstitution syndrome
D89.3 is not a CMS-HCC payment code. MEAT criteria · RAF Calculator · free HCC coding tools
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) / Certain disorders involving the immune mechanism (D80-D89)
D89.3
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceImmune reconstitution syndrome
A syndrome that occurs when the immune system rapidly recovers after being suppressed, causing inflammation and tissue damage, often seen in HIV/AIDS patients starting antiretroviral therapy.

Buddy Insight
Immune reconstitution inflammatory syndrome occurs when a recovering immune system mounts an excessive inflammatory response to previously acquired infections or antigens.
CMS-HCC V28
N/A—
Not mapped
CMS-HCC V24
HistoricalHistorical
Not used for CY2026 payment
ACA/HHS
MappedHCC 074
Code-level coefficient reference
ESRD/PACE
MappedHCC 47
Code-level coefficient reference
RXHCC
MappedHCC 99
Code-level coefficient reference
Code Book Path
Inclusion Terms
Official- Immune reconstitution inflammatory syndrome [IRIS]
Excludes 2
Official- autoimmune disease (systemic) NOS (M35.9)Inherited from D50-D89, D89
- certain conditions originating in the perinatal period (P00-P96)Inherited from D50-D89, D89
- complications of pregnancy, childbirth and the puerperium (O00-O9A)Inherited from D50-D89, D89
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)Inherited from D50-D89, D89
- endocrine, nutritional and metabolic diseases (E00-E88)Inherited from D50-D89, D89
- human immunodeficiency virus [HIV] disease (B20)Inherited from D50-D89, D89
- injury, poisoning and certain other consequences of external causes (S00-T88)Inherited from D50-D89, D89
- neoplasms (C00-D49)Inherited from D50-D89, D89
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)Inherited from D50-D89, D89
- transplant failure and rejection (T86.-)Inherited from D50-D89, D89
Related Codes
Includes
Official- defects in the complement systemInherited from D80-D89
- immunodeficiency disorders, except human immunodeficiency virus [HIV] diseaseInherited from D80-D89
- sarcoidosisInherited from D80-D89
Excludes 1
Official- autoimmune disease (systemic) NOS (M35.9)Inherited from D80-D89, D89
- functional disorders of polymorphonuclear neutrophils (D71-)Inherited from D80-D89, D89
- human immunodeficiency virus [HIV] disease (B20)Inherited from D80-D89, D89
- hyperglobulinemia NOS (R77.1)Inherited from D80-D89, D89
- monoclonal gammopathy (of undetermined significance) (D47.2)Inherited from D80-D89, D89
Code First
OfficialNo Code First sequencing instructions are included in this display for D89.3. Check the code and parent instructions in the Code Book.
Use Additional
Official- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Code Also
OfficialNo Code Also instructions are included in this display for D89.3. Check the code and parent instructions in the Code Book.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is D89.3 an HCC code?
D89.3 is not in the CMS-HCC V28 or V24 community payment model. D89.3 has a separate mapping under the CMS-HCC ESRD model (HCC 47 (Disorders of Immunity)) and the Part D RxHCC model (HCC 99 (Immune Disorders)); the applicable result needs member context. D89.3 also appears in the HHS-HCC commercial risk model (HCC 074 (HHS-HCC 074 adult, RAF varies by metal level)), which is a commercial market model rather than a Medicare Advantage payment mapping.
- Code
- D89.3
- Description
- Immune reconstitution syndrome
- HCC (V28)
- No CMS-HCC V28 mapping
- RAF reference coefficient
- —
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.
Work D89.3 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →
MEAT review for D89.3
For D89.3, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Coder workflow notes
Get the V28 mapping + MEAT cheat sheet
One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
D89.3 is the ICD-10-CM diagnosis code for immune reconstitution syndrome. A syndrome that occurs when the immune system rapidly recovers after being suppressed, causing inflammation and tissue damage, often seen in HIV/AIDS patients starting antiretroviral therapy. D89.3 sits in the ICD-10-CM chapter for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (d50-d89), within the section covering certain disorders involving the immune mechanism (d80-d89).
D89.3 has no mapping under the CMS-HCC V28 or V24 community payment models. D89.3 has a separate mapping under the CMS-HCC ESRD model (HCC 47 (Disorders of Immunity)) and the Part D RxHCC model (HCC 99 (Immune Disorders)); the applicable result needs member context. D89.3 also appears in the HHS-HCC commercial risk model (HCC 074 (HHS-HCC 074 adult, RAF varies by metal level)), which is a commercial market model rather than a Medicare Advantage payment mapping. Do not assign V28 risk adjustment value from this page; verify the applicable model and payment year before using this code for risk adjustment.
This code is commonly used in immunocompromised patients, particularly those with HIV starting treatment.
HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for D89.3 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •This code is commonly used in immunocompromised patients, particularly those with HIV starting treatment
- •Document the specific manifestations and affected organs for complete clinical picture
Clinical Significance
Immune reconstitution inflammatory syndrome occurs when a recovering immune system mounts an excessive inflammatory response to previously acquired infections or antigens. It is most commonly seen in HIV patients initiating antiretroviral therapy but also occurs after discontinuation of immunosuppressive medications or following stem cell transplantation. The paradoxical worsening despite treatment improvement can be life-threatening, particularly with central nervous system involvement.
Documentation Requirements
- ✓Documentation must clearly establish the diagnosis of immune reconstitution syndrome, the temporal relationship to immune recovery (initiation of antiretroviral therapy, discontinuation of immunosuppressive drugs, or post-transplant engraftment), and the specific infectious or inflammatory trigger.
- ✓The provider should document the patient's immune recovery markers (rising CD4 count, decreasing viral load) and the clinical manifestations requiring treatment.
Use Additional Code
Commonly Confused Codes
- •B20 (Human immunodeficiency virus disease) should be coded as the underlying condition when applicable but does not replace D89.
- •T86.- (Complications of transplanted organs and tissue) may be more appropriate if the clinical picture is graft rejection rather than immune reconstitution. D89.89 (Other specified disorders involving the immune mechanism) is a less specific alternative that should not be used when immune reconstitution syndrome is confirmed.

